1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Malignant Peritoneal Mesothelioma, Advanced: new trials by email Literature Review of Malignant Peritoneal Mesothelioma, Advanced trials Research Report on Malignant Peritoneal Mesothelioma, Advanced
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM Sintilimab, Bevacizumab , Pemetrexed , Cisplatin - Malignant Peritoneal Mesothelioma, Advanced | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 28 | 2024-01-31 | 2024-08-07 |
Bevacizumab (1) · Cisplatin (1) · Pemetrexed (1) · sintilimab (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)
China (1)